We have compared the effects of an increase in perfusate viscosity induced by dextran and by hematocrit (Hct) on segmental vascular resistance in the pulmonary circulation and the effect of flow on microvascular resistance in lungs perfused with dextran and red blood cells. We isolated and perfused lungs of 39 neonatal rabbits weighing 670±250 g. To determine the effect of dextran, group 1 (n =8) lungs were perfused with both 5% and 20o dextran 70 solutions (Hct, -25%); to determine the effect of Hct, group 2 (n=5) lungs were perfused alternately with 5% and 40% Hct solutions (5% dextran 70). In group 1 and group 2 lungs, experiments were done at constant flow and pressure. Group 3 and group 4 (each n=4) lungs were perfused with 5% and 20% dextran 70, respectively (0 Hct); group 5 (n =5), with 10% dextran 70; group 6 (n=7), with 5% dextran 500; and group 7 (n=6), with 20% dextran 70 (Hct, -5%). All lungs were perfused in zone 3; airway and left atrial pressures were 6 and 8 cm H20, respectively. To partition the circulation, we measured pressures in the pulmonary artery and left atrium continuously and pressures in 20-50-,um arterioles and 20-50-gm venules by micropuncture.
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We have compared the effects of an increase in perfusate viscosity induced by dextran and by hematocrit (Hct) on segmental vascular resistance in the pulmonary circulation and the effect of flow on microvascular resistance in lungs perfused with dextran and red blood cells. We isolated and perfused lungs of 39 neonatal rabbits weighing 670±250 g. To determine the effect of dextran, group 1 (n =8) lungs were perfused with both 5% and 20o dextran 70 solutions (Hct, -25%); to determine the effect of Hct, group 2 (n=5) lungs were perfused alternately with 5% and 40% Hct solutions (5% dextran 70). In group 1 and group 2 lungs, experiments were done at constant flow and pressure. Group 3 and group 4 (each n=4) lungs were perfused with 5% and 20% dextran 70, respectively (0 Hct); group 5 (n =5), with 10% dextran 70; group 6 (n=7), with 5% dextran 500; and group 7 (n=6), with 20% dextran 70 (Hct, -5%). All lungs were perfused in zone 3; airway and left atrial pressures were 6 and 8 cm H20, respectively. To partition the circulation, we measured pressures in the pulmonary artery and left atrium continuously and pressures in 20-50-,um arterioles and 20-50-gm venules by micropuncture.
We found that an increase in both the concentration and molecular weight of dextran increased perfusate viscosity and the resistance in all three longitudinal vascular segments: arteries, microvessels, and veins. However, Hct-induced increases in perfusate viscosity resulted in an increase in arterial and venous resistances alone, with no increase in microvascular resistance. In group 1 and group 7 lungs, which were perfused with 20% dextran 70 but with varying Hcts, a greater than 50%o increase in flow rate resulted in a greater decrease in microvascular resistance in group 1 lungs that had a higher Hct. Our results indicate that dextran-induced viscosity effects are present in all three vascular segments of the pulmonary circulation, whereas Hct effects are found mainly in arteries and veins greater than 50 ,um in diameter. Microvascular resistance is altered by flow rate and may also be influenced by dextran-red blood cell interactions. (Circulation Research 1991; 68:1108 -1116 T he pulmonary circulation is comprised of a complex network of blood vessels, with each successive segment (arterial, microvascular, and venous) demonstrating unique pressure-flow characteristics. The differences in the responses of these three vascular segments to a variety of stimuli are, in part, due to the intrinsic vasomotor properties of the blood vessels as well as their passive viscoelastic properties. In addition, the microrheological behavior of blood may vary in the three segments of the pulmonary vasculature, leading to different hemodynamic events in the three vascular segments. The interactions of plasma constituents with the various circulating cells in blood are complex. In general, our knowledge of blood rheology is derived from in vitro studies using cone-plate viscometers and microtube viscometry. However, results from in vivo studies appear to be in conflict with the known behavior of blood determined from in vitro studies,1-3 with the most discrepancy existing between blood apparent viscosity measured at different shear rates in vitro and actual pressure drops measured in vivo. Therefore, it is important that we determine blood rheological effects in whole organ and in vivo studies in addition to in vitro studies. It is particularly important in the lung, because disturbances in microcirculatory hemodynamics not only affect gas exchange but also influence transvascular fluid and protein flux. We4 have previously reported that, in the pulmonary circulation, hematocrit-induced increases in perfusate viscosity resulted in an increase in total vascular resistance, mainly by increasing the resistance in arteries and veins, without affecting the resistance in microvessels less than 50 gm in diame-ter. We had postulated that the lack of an effect of hematocrit in microvessels might be mainly due to a significant reduction in microvessel hematocrit (Fahraeus effect5, 6) and only in small part due to vascular distension and recruitment of microvessels. The purpose of this study was to determine the effect of dextran-induced increases in perfusate viscosity on segmental vascular resistance in the lung and to compare these effects with those of hematocrit. We hypothesized that, if the lack of an effect in microvessels with hematocrit that we had observed was indeed due to vascular distension and recruitment and not due to a Fahraeus effect, a comparable increase in perfusate viscosity induced by dextran should also not affect microvascular resistance. Conversely, if the Fahraeus effect is significant in the pulmonary circulation, a dextran-induced increase in perfusate viscosity should increase microvascular resistance.
Materials and Methods

Isolated Perfused Lung Preparation
Lungs of 39 rabbits, 4-5 weeks of age, with an average body weight of 670±250 g were isolated and perfused as previously described by US.7 Animals were given 1,000 IU/kg body wt i.v. heparin sodium, followed by a lethal dose of 50 mg/kg body wt sodium pentobarbital via an ear vein. An endotracheal tube was tied into the trachea, and via a sternotomy, the heart and lungs were removed from the chest. Cannulas filled with 5% dextran 70 (MW 66,000-70,000) in Ringer's lactate solution were tied into the pulmonary artery via the right ventricle and into the left atrium via the left ventricle and connected to the perfusion circuit. Time from death of the rabbit to perfusion of the lungs was less than 10 minutes.
To eliminate any active vasomotion, we paralyzed the vasculature by adding papaverine hydrochloride to the perfusate to achieve a concentration of approximately 70 ,ug/ml. 89 We have previously confirmed that this concentration of papaverine is adequate to completely paralyze the vasculature in rabbit lungs.9 Perfusate Po2 ranged from 100 to 180 mm Hg. Fifty percent glucose solution was added if necessary to maintain glucose concentration in the perfusate between 90 and 150 mg% as measured by Dextrostix (Ames, Elkhart, Ind.). A heat exchanger (Miniprine, Travenol, Deerfield, Ill.) in the circuit maintained perfusate temperature at 37°C, a 40-,um filter (Ultipore, Pall Biosupport Corp., Glen Cove, N.Y.) removed any large particles, and a bubble trap in the circuit acted as a depulsator. Perfusate flow was controlled with a calibrated flow pump (roller pump, Masterflex, Cole-Parmer Instrument Co., Chicago), and left atrial pressure was adjusted by the height of the venous reservoir. Pulmonary arterial and left atrial pressures were measured with Gould-Statham P23 transducers (Gould, Cleveland, Ohio) and continuously recorded (polygraph, Beckman Instruments, Inc., Fullerton, Calif.). Zero reference the lung, the site of all micropunctures. All the lungs were perfused under zone 3 conditions10; airway and left atrial pressures were 6 and 8 cm H2O, respectively. Perfusate 02 and CO2 tensions, pH (Radiometer CM5 3MK2, Radiometer America, Inc., Westlake, Ohio), and hematocrit were monitored every 5-10 minutes. The lungs, except for the site of micropuncture, and the venous reservoir were covered with plastic wrap to prevent diffusive losses of carbon dioxide. The experiments were terminated before the appearance of edema fluid in the trachea.
Microvascular Pressure Measurements
We used micropipettes and the servonulling technique to measure pressures in subpleural 20-50-,umdiameter arterioles and 20-50-,um-diameter venules.1112 Glass micropipettes with a tip diameter of 2-4 gm were filled with 1.2 M NaCl colored with green dye and connected electrically and hydraulically to a servonull pressure measuring system (model 4A, Instruments for Physiology & Medicine, Inc., San Diego). The lung surface was stabilized with a small plastic ring attached to a stand; the ring diameter was 1.5 cm. A microdrip of normal saline was attached to the plastic ring, so that a pool of normal saline was always present on the lung surface for obtaining the servonull zero reference pressure. Subpleural vessels were viewed through a stereomicroscope (Zeiss, FRG) at x80 magnification with illumination from a cold light source (Intralux 5000, Volpi Manufacturing USA, Inc., Auburn, N.Y.). Venules were identified by observing the direction of flow of red blood cells from small to larger vessels and from large to smaller vessels in the case of arterioles. Valid microvascular pressure measurements fulfilled the standard criteria.1',12 Experimental Protocols Seven groups of lungs were perfused with different dextran solutions dissolved in Ringer's lactate, with and without suspended red blood cells.
Group 1 lungs (n=8). To determine the effect of a dextran-induced increase in perfusate viscosity on total and segmental vascular pressure resistances, we perfused the lungs with both 5% dextran 70 and 20% dextran 70 (MW 66,000-70,000, Sigma Chemical Co., St. Louis) solutions in Ringer's lactate, with a mean hematocrit of 25.4+4.1% in both perfusates. The sequence of perfusion with 5% and 20% dextran 70 solution was alternated in each lung. The effect of 20% dextran 70 on segmental vascular resistance was determined at constant flow (80 ml . kg`1 min-m) and constant total arteriovenous pressure drop (-13 cm H2O). During perfusion with 20% dextran 70, flow was reduced to 33.2+8.7 ml * kg`1 * min-1 to obtain the same total arteriovenous pressure drop as during perfusion with 5% dextran 70. Group 2 lungs (n=5). To determine the effect of hematocrit on segmental vascular resistance, we perfused this group of lungs at a flow rate of 80 1109 level for vascular pressures was the topmost part of ml kg-1 min-1, with perfusates of 5% dextran 70 solutions with 4.9+1.2% and 40.4+6.0% hematocrits, respectively. The sequence of perfusion with low and high hematocrit was alternated in each lung. During perfusion with the higher hematocrit solution, flow was lowered to 45.2±+10.8 ml* kg-min-1 to obtain the same total arteriovenous pressure drop that occurred during perfusion with the lower hematocrit solution (-8 cm H20).
Group 3 and group 4 lungs (each n=4). To determine the effect of a dextran-induced increase in perfusate viscosity in the absence of red blood cells, we perfused these two groups of lungs with 5% and 20% dextran 70 solutions, respectively; hematocrit was 0%. Flow was constant in all lungs at 80 ml * kg`1 min-l. Microvascular pressures were not obtained in these lungs.
Group 5 (n=5) and group 6 (n= 7) lungs. To determine the effect of an increase in perfusate viscosity induced by an increase in concentration and molecular weight of dextran on segmental vascular resistance, we perfused group 5 lungs with 10% dextran 70 solution and group 6 lungs with 5% dextran 500 (MW 503,000, Sigma Chemical). Flow rate was 80 ml . kg`1 min-l. These two perfusates were selected because the osmolarity of each of these solutions was not significantly higher than that of 5% dextran 70. To facilitate microvascular pressure measurements by micropuncture, washed adult rabbit red blood cells were added to the perfusate in an amount sufficient for easy detection of the direction of flow in surface vessels. Average hematocrit of perfusate for these lungs was 3.3±1.6%.
Group 7 lungs (n=6). To determine the effect of flow rate on segmental vascular resistance in lungs perfused with high concentrations of dextran, we perfused this group of lungs with 20% dextran 70, 6.9±1.1% hematocrit, at flow rates of 80.0 and 30.0±7.0 ml * kg-1* min`and measured pulmonary artery and microvascular pressures. We compared the effects of flow rate on segmental vascular resistance in group 7 lungs with the effects of flow rate in group 1 lungs to determine if red blood cell-dextran interactions were significant in low flow states.
Viscosity and Osmolarity Measurement
In each experiment, 1.0 ml perfusate was obtained for measurement of in vitro viscosity, using a cone-plate viscometer (Brookfield Engineering Laboratory, Inc., Stoughton, Mass.). Viscosity measurements were obtained at 37°C and at 0.3, 0.6, 3, 6, 12, 30, and 60 rpm, corresponding to a shear rate of 1.15, 2.3, 11.5, 23, 46, 115, and 230 sec`l. The apparent viscosity of the perfusate samples was calculated.
Osmolarity of the perfusate solutions was measured using a micro-osmometer (model 3MO, Advanced Instruments, Inc., Needham, Mass.). 
Data Analyses
All data are expressed as mean+SD for each group of lungs. To compare longitudinal segmental vascular pressure drops in each group of lungs, we used an analysis of variance and applied the Student-Newman-Keuls test. For group 1 and 2 lungs, we used an analysis of variance to compare vascular pressures, segmental vascular pressure drops, and segmental vascular resistances during the three experimental conditions. We compared vascular pressures and segmental vascular pressure drops among group 2, 5, 6, and 7 lungs obtained when the lungs were being perfused with low hematocrit solutions (-5%) and used an analysis of variance with the Student-Newman-Keuls test to detect significant differences. We accepted p<0.05 as indicative of statistical significance. Table  1 and Figure 3 . In the first phase of the experiment, during perfusion with 5% dextran 70 solution at a flow rate of 80 ml kgl * min-1, total arteriovenous pressure drop was 14.8 cm H20, with approximately 40% of the total pressure drop in arteries, 20% in microvessels (<50 ,um in diameter), and 40% in veins. When we changed the perfusate to 20% dextran 70, at the same flow rate, total arteriovenous 0.6- Total arteriovenous pressure drop was 6.0±0.5 cm H20 in group 3 lungs and 13.0±2.0 cm H20 in group 4 lungs. Pulmonary vascular pressures and segmental vascular pressure drops obtained in group 2, 5, 6, and 7 lungs during perfusion with a flow rate of 80 ml . kg`1 min-1 and a hematocrit of approximately 5% are shown in Figures 5 and 6 , respectively. With a significant increase in perfusate viscosity, total arteriovenous pressure drop increased. Pulmonary artery, arteriolar, and venular pressures also increased, as did the pressure drop in all three vascular segments. However, the percent increase in total 7. Graph showing effect ofan increase in flow from 30-33 to 80 ml * kg`* min on total and segmental vascular resistance expressed as percent decrease in resistance from baseline in two groups of lungs perfused with 20% dextran 70 (D 70) solution and varying hematocrit (HCT) (25% HCT in group 1 and 7% HCT in group 7) . For a comparable increase in blood flow, the decrease in total vascular resistance was greater in group 1 lungs, mainly due to a greater reduction in microvascular resistance.
Results
Osmolarity
Comparison of the Effect of Flow Rate on Segmental Vascular Resistance in Lungs Perfused with 20%
Dextran 70 Solutions and Two Different Hematocrits Hematocrits were 25% in group 1 and 7% in group 7. In group 7 lungs, at the lower flow rate (30+7 ml* kg`. min-m), we found that total pulmonary vascular resistance was significantly higher ( Table 3 ). All vascular pressures were lower at the lower flow rate, but the calculated vascular resistances in arteries, microvessels, and veins were higher. In Figure 7 , we have compared the effect of an increase in blood flow from 30-33 to 80 ml* kg`1 min1in group 1 and 7 lungs. In group 1 lungs, the decrease in total vascular resistance was greater than in group 7 lungs. This was mainly due to a greater decrease in resistance in the microvascular segment.
Discussion
The resistance to blood flow in the pulmonary circulation is determined by the product of vascular hindrance and blood viscosity. The major factors that regulate the apparent viscosity of blood are plasma viscosity, cell concentration, cell deformation, and cell aggregation. Since red blood cells are present in the largest numbers in blood, it is the behavior of red blood cells that primarily influences blood viscosity. These various factors are not independent of each other; that is, an increase in plasma protein concentration will not only affect plasma viscosity but may also affect red blood cell aggregation. Furthermore, in the pulmonary circulation, there is probably a profile of shear rates. Though it is difficult to determine the exact shear rates present in the different longitudinal vascular segments, estimates made in the systemic circulation indicate that the lowest shear rates are present in postcapillary venules. 13 The effect of shear rate on blood apparent viscosity is significant, with a decrease in viscosity with high shear rates due to red blood cell deformation and disaggregation. And, finally, the mechanical behavior of successive segments of the pulmonary vasculature is different; the microvascular segment is capable of reducing its vascular hindrance by both distension and recruitment, but in arteries and veins vascular hindrance is reduced mainly by distension. Therefore, the physiological effect in vivo brought about by biorheological alterations in the properties of blood cannot always be predicted. In this study, we have determined the effect of a dextran-induced increase in perfusate viscosity on segmental vascular resistance in the lung and compared this effect with that induced by an increase in perfusate hematocrit. We have also studied the influence of flow rate on dextran-red blood cell interactions in the pulmonary microcirculation.
Effect of Dextran-Induced Increases in Perfusate Viscosity on Total and Segmental Vascular Resistance in the Lung
Plasma is mainly a solution of crystalloids and proteins in water, and it is the nature and the concentration of plasma proteins that determine the viscosity of plasma. The larger the effective size of proteins and the greater the number of protein molecules present in solution, the higher is the viscosity of the fluid.14 In our experiments, we simulated changes in plasma protein content and composition by changing both molecular weight and concentration of dextran molecules in solution.
In general, at constant flow, the effect of an increase in perfusate viscosity, as measured by in vitro cone-plate viscometry, was an increase in total arteriovenous pressure drop (Figure 2 ). During perfusion with 5% dextran solution with no red blood cells (viscosity, 2 cP), the total arteriovenous pressure drop in the lungs at a flow of 80 ml* kg.* min-1 was 6.0+0.5 cm H20 (group 3). This pressure drop is probably entirely due to vascular hindrance, because viscous resistance is negligible. A similar high resistance value in spite of the low perfusate viscosity has been described for other tissues. 15 Next, we found that the addition of a small number of red blood cells (hematocrit, -4%) had a very marked effect on perfusate apparent viscosity, but a further increase in hematocrit to 25% and 40% had a much smaller effect on apparent viscosity. The increase in in vitro apparent viscosity of perfusate by the addition of red blood cells correlated well with the increase in total arteriovenous pressure drop at constant flow. However, the relation between total pulmonary vascular resistance and perfusate viscosity was not directly proportional. The percent increase in pulmonary vascular resistance was always lower than the percent increase in perfusate viscosity. The most likely explanation for this is passive distension and recruitment of the pulmonary vessels during perfusion with higher intravascular pressures, mainly in the microvascular segment. 16 We have considered the possibility that some of the increase in pulmonary vascular resistance during perfusion with 20% dextran 70 solution may have been due to an increase in osmolarity of the solu-active vasomotion could have been possible, changes in osmolarity could have induced fluid shifts across cells and shape changes in endothelial and smooth muscle cells, resulting in changes in vascular geometry. In a recent study using an isolated canine lung lobe preparation with unparalyzed vasculature, Hakim17 examined the effect of solutions of different osmolarities, with and without added red blood cells, on pulmonary vascular resistance. He did not find any significant effect on vascular resistance when plasma osmolarity ranged from 260 to 350 mosm/l. Only when the osmolarity was lower than 250 mosm/l or higher than 350 mosm/l did pulmonary vascular resistance increase. He also found that this effect was exaggerated in the presence of red blood cells. In our study, the osmolarity of the perfusates ranged from 265 to 340 mosm/l, and in group 5, 6, and 7 lungs, there were very few red blood cells in the perfusate. Hence, it is unlikely that the osmolarity of the perfusates was responsible for the increase in pulmonary vascular resistance.
We did not measure the colloidal oncotic pressures of the different perfusates. It is possible that the increase in resistance to flow was influenced by increases in colloidal oncotic pressure and also by inducing transcapillary fluid shifts and alterations in vascular geometry. Although it is certain that the colloidal oncotic pressure of 20% dextran 70 solution must be considerably greater than that of 5% dextran 70, it is very likely that the oncotic pressure of 5% dextran 500 is lower than that of 5% dextran 70. Yet, the directional change in vascular resistance was always in the direction of viscosity change. Hence, we believe that the increase in resistance to flow was primarily due to an increase in perfusate viscosity.
In all our experiments, we found that an increase in perfusate viscosity induced by dextran always resulted in an increase in resistance in all three vascular segments. Microvascular resistance always increased even under constant flow conditions when all vascular pressures were elevated and considerable distension and recruitment of microvessels was possible.
Effect of Hematocrit-Induced Increases in Perfusate Viscosity on Segmental Vascular Resistance: Comparison With the Effect of Dextran
An increase in hematocrit from 5% to 40% resulted in a significant increase in perfusate apparent viscosity and total vascular resistance. However, this increase was mainly due to an increase in resistance in arteries and veins, with no change in microvascular resistance. These results are similar to those we have previously reported4; when hematocrit was changed from 18% to as high as 78%, there was no change in microvascular resistance. As we have previously suggested, one explanation might be that, although large vessel hematocrit increased significantly, microvessel hematocrit must have changed very little. Fahraeus and Lindqvist6 first demonstrated that, as tube diameter is reduced below 300 ,um, apparent viscosity of tions. Although the vasculature was paralyzed and no red blood cell suspensions decreases as a result of an actual decrease in small tube hematocrit.5 In the systemic circulation, studies conducted in vivo have confirmed this effect in microvessels; hematocrit starts decreasing in vessels smaller than 70 ,gm and reaches a value of less than 25% of systemic hematocrit in capillaries.18 However, though no direct measurements of microvascular hematocrit have been made in the pulmonary circulation, data from indirect methods, such as by comparison of plasma and red blood cell transit times, have yielded estimates of microvascular to large vessel hematocrit that vary from less than 0.50 to 0.90. [19] [20] [21] Our data would support the presence of significant reduction of hematocrit in lung microvessels, because we found that, for a comparable increase in perfusate viscosity induced by dextran and hematocrit, dextran resulted in a significant increase in microvascular resistance whereas hematocrit did not.
Another possibility is that the Fahraeus effect is significant only in subpleural vessels, since they are long and tubular22 and negligible in the bulk of the capillaries in the body of the lung. Our technique limits us to measurement of pressures in the subpleural microcirculation, and hence, at the present time, we cannot rule out this possibility.
Effect of Flow Rate and Hematocrit on Microvascular Resistance in Lungs Perfused With 20% Dextran 70 Solution (Group 1 and 7 Lungs)
In general, the effect of an increase in blood flow and total arteriovenous pressure drop is a decrease in pulmonary vascular resistance that is mainly due to vascular distension and recruitment. Some of the reduction in total resistance is also due to a reduction in apparent viscosity of blood. An increase in shear rate results in greater deformation of red blood cells23-25 and also in deaggregation of red blood cells,26 thus, resulting in a reduction in effective red blood cell volume. We found a greater (30% versus 20%) reduction in total vascular resistance in lungs perfused with a higher hematocrit (25% versus 7%). This difference was due to a greater reduction in microvascular resistance (38% versus 22%). We speculate that this effect in microvessels may be due to a combination of red blood cell deformation and deaggregation. No such effect of flow on microvascular resistance was seen in group 2 lungs that were perfused with 5% dextran 70 and varying hematocrit, at least at the flow rates that we studied. Maximum red blood cell aggregation has been shown to occur at an optimum concentration of dextran approximating 4 g%, with a decreasing tendency to aggregation with higher concentrations of dextran. 27 However, our data seem to indicate that at comparable flow rates significant red blood cell aggregation occurs in solutions of 20% dextran 70 and not 5% dextran 70. The relation between the extent of red blood cell aggregation and shear rate of flow appears to be quite complex. In vitro studies done in vertical tubes of different sizes have demonstrated different results from those obtained with a cone-plate viscometer: the relative viscosity of an aggregating solution did not increase with decreasing shear rate in vertical tubes.28 However, the viscous properties of blood in horizontal tubes appear to be similar to that observed in rotational viscometry. To further elucidate the precise microrheological events occurring in the pulmonary microcirculation, we will have to perform many more experiments beyond the scope of this study.
Finally, a word about the limitations of the micropuncture technique. With this technique, we can determine the anatomic resistance sites with accuracy; however, because the data are obtained in the subpleural microcirculation, we have to extrapolate them to the rest of the circulation. In circumstances in which the distribution of blood flow changes from one experimental condition to the other, a constant flow condition may not exist for the subpleural region. At the present time, we are unable to determine the exact flow in the vessels we puncture or to determine microvessel hematocrit, measurements that would greatly enhance our study. There are, however, no data to suggest that the distribution of blood flow within the lung changes with changes in perfusate characteristics; hence, we believe that our data are probably true for the entire lung.
In summary, we have shown that dextran-induced increases in perfusate viscosity result in an increase in resistance in all three longitudinal vascular segments of the lung but that a comparable increase in perfusate viscosity induced by hematocrit results in an increase in resistance in arteries and veins only, with no change in microvascular resistance. Thus far, much of our knowledge related to rheological effects in the microcirculation is derived from studies done in the systemic microcirculation. The size and distensibility of pulmonary capillaries is different from that of systemic capillaries, making separate study of rheology of the pulmonary microcirculation essential. Such knowledge will enable us to optimize pulmonary capillary flow in clinical conditions associated with abnormalities of hematocrit and colloid content of blood.
